EPS for ChemoCentryx, Inc. (CCXI) Expected At $-0.29

Retrieved on: 2018-04-29 13:37:30

Tags for this article:

Finance

NASDAQ

Economy of New York City

S&P 500 INDEX - CBOE

CCR2

Click the tags to see associated articles and topics

EPS for ChemoCentryx, Inc. (CCXI) Expected At $-0.29. View article details on hiswai:

Excerpt

<div>23.51 million shares or 1.03% less from 23.75 million shares in 2017Q3 were reported. Bb&T Limited Co holds 83,500 shares. Nantahala Cap Mgmt invested 0.25% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). 438,838 are owned by <b>Acadian Asset Management</b> Ltd Limited Liability Company.</div>

Article found on:

View Original Article